Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Blanche Valnet-Rabier

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Vaccines|February 24, 2024
Sudden Sensorineural Hearing Loss after COVID-19 Vaccination: A Review of the Available Evidence through the Prism of Causality AssessmentHung Thai-Van, Haleh Bagheri, Marie-Blanche Valnet-Rabier
Seminars in Oncology|April 12, 2026
Pregnancy during pembrolizumab therapy for triple-negative breast cancer with onset of congenital hypothyroidism: Case report, literature review, and caution for clinical practiceAntonin Vagnet, Maia Ferraj, Erion Dobi, et al.
Case Reports in Rheumatology|July 12, 2013
Acute pancreatitis occurring after pamidronate infusions in two patients with spondyloarthritisEric Toussirot, Lucine Vuitton, Stéphane Koch, et al.
Therapie|December 18, 2012
[Safety update on vaccination during pregnancy]Mélanie Moltenis, Marie-Blanche Valnet-Rabier, Joël Leroy, et al.
Therapie|February 8, 2023
Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemicAurélie Grandvuillemin, Fanny Rocher, Marie Blanche Valnet-Rabier, et al.
British Journal of Clinical Pharmacology|October 4, 2024
Economic burden of hospital admissions for adverse drug reactions in France: The IATROSTAT-ECO studyMarie-Laure Laroche, Noémie Tarbouriech, Taha Jai, et al.
Therapie|March 27, 2025
[Pharmacovigilance notification by dental surgeons in France: A ten-year analysis of the French database]Antonin Vagnet, Hélène Peyrouzet, Viktoryia Prontskus, et al.
Therapie|June 1, 2022
[HIV preexposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine: What about safety?]Carine Jacomet, Christine Lebeller, Thomas Schiestel, et al.
Therapie|January 11, 2022
Epidemiology and economic burden of "serious" adverse drug reactions: Real-world evidence research based on pharmacovigilance dataMarion Tissot, Marie-Blanche Valnet-Rabier, Thomas Stalder, et al.
Therapie|September 9, 2018
[Acceptability and effectiveness of immunotherapy in patients with melanoma]Marie-Blanche Valnet-Rabier, Charles Marcucci, Samuel Limat, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Vaccines|February 24, 2024
Sudden Sensorineural Hearing Loss after COVID-19 Vaccination: A Review of the Available Evidence through the Prism of Causality AssessmentHung Thai-Van, Haleh Bagheri, Marie-Blanche Valnet-Rabier
Seminars in Oncology|April 12, 2026
Pregnancy during pembrolizumab therapy for triple-negative breast cancer with onset of congenital hypothyroidism: Case report, literature review, and caution for clinical practiceAntonin Vagnet, Maia Ferraj, Erion Dobi, et al.
Case Reports in Rheumatology|July 12, 2013
Acute pancreatitis occurring after pamidronate infusions in two patients with spondyloarthritisEric Toussirot, Lucine Vuitton, Stéphane Koch, et al.
Therapie|December 18, 2012
[Safety update on vaccination during pregnancy]Mélanie Moltenis, Marie-Blanche Valnet-Rabier, Joël Leroy, et al.
Therapie|February 8, 2023
Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemicAurélie Grandvuillemin, Fanny Rocher, Marie Blanche Valnet-Rabier, et al.
British Journal of Clinical Pharmacology|October 4, 2024
Economic burden of hospital admissions for adverse drug reactions in France: The IATROSTAT-ECO studyMarie-Laure Laroche, Noémie Tarbouriech, Taha Jai, et al.
Therapie|March 27, 2025
[Pharmacovigilance notification by dental surgeons in France: A ten-year analysis of the French database]Antonin Vagnet, Hélène Peyrouzet, Viktoryia Prontskus, et al.
Therapie|June 1, 2022
[HIV preexposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine: What about safety?]Carine Jacomet, Christine Lebeller, Thomas Schiestel, et al.
Therapie|January 11, 2022
Epidemiology and economic burden of "serious" adverse drug reactions: Real-world evidence research based on pharmacovigilance dataMarion Tissot, Marie-Blanche Valnet-Rabier, Thomas Stalder, et al.
Therapie|September 9, 2018
[Acceptability and effectiveness of immunotherapy in patients with melanoma]Marie-Blanche Valnet-Rabier, Charles Marcucci, Samuel Limat, et al.
Pageof 4